CYW-628

N/A

Report date: 2025/08/02 20:00:11

Base Information

Drug NameCYW-628
Drug Alias NameCYW-628CYW628CYWC-628
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Dermal fibroblasts therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsUlcerDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFibroBiologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFibroBiologics Inc
Inactive CompaniesN/A
Active IndicationsUlcerDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A